Mechanisms of cellular activation by platelet microparticles

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 794-800

  Barry, Orla P ^b   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C; PROTEIN KINASE C;

ATHEROGENESIS; BLOOD CLOTTING; CELL ACTIVATION; CELL MEMBRANE; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0032725206     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615913     Document Type: Conference Paper

References (65)

1. Armstrong MJ, Storch J, Dainiak N. Stimulating distinct plasma membrane regions gives rise to extracellular membrane vesicles in normal and transformed lymphocytes. Biochim Biophys Acta. 1998;946:106-112.
2. Bos-Vreugdenhil AP, Poldermans JE, Ruitenbeek MM, Nieuw-Amerongen AV, Roukema PA. Study on membrane fragments released from the sublingual glands of the mouse during secretion in vitro and in vivo. J Biol Buccale. 1985;13:317-332.
3. Satta N, Toti F, Feugeas O, Bohbot A, Dachery-Prigent J, Eschwege V, Hedman H, Freyssinet JH. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153:3245-3255.
4. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. Circulation. 1999;99:348-353.
5. Leeuwenberg JF, Smeets EF, Neefjies JJ, Shaffer MA, Cinek T, Jeunhomme TM, Ahern TJ, Buurman WA. E-selectin and intracellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology. 1992;77:543-549.
6. 2+-induced biochemical changes in human erythrocytes and their relation to microvesiculation. Biochem J. 1981;198:433-440.
7. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen P, ten Have L, Kijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997;96:3534-3541.
8. Gris J-C, Toulon P, Brun S, Maugard C, Sarlat C, Schved J-F, Berlan J. The relationship between plasma microparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection. Thromb Haemost. 1996;76:38-45.
9. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali J-L, Freyssinet J-M. The significance of shed membrane particles dur-ing programmed cell death in vitro and in vivo in HIV-1 infection. J Clin Invest. 1997;99:1546-1554.
10. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988;263:18205-18212.
11. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem. 1989;264:17049-17057.
12. Fox JEB, Austin CD, Boyles JK, Steffen PK. Role of the membrane cytoskeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol. 1990;111:483-493.
13. Fox JEB, Austin CD, Reynolds CC, Steffen DK. Evidence that agonist-induced activation of calpain causes shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem. 1991;266:13289-13295.
14. Yano Y, Shiba E, Kambayashi J-I, Sakon M, Kawasaki T, Fujitani K, Kang J, Mori T. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane. Thromb Res. 1994;71:385-396.
15. Basse F, Gaffet P, Bienvenue A. Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effects of calpain during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation. Biochem Biophys Acta. 1994;1190:217-224.
16. Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity. Physiological significance and mechanisms of exposure. Blood Rev. 1991;5:146-154.
17. 2+-ATPase inhibitors. Biochemistry. 1995;34:11625-11634.
18. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 1996;88:3456-3464.
19. Holme PA, Orvim U, Hamers MJAG, Solum NO, Brosstad FR, Barstad RM, Sakariassen KS. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arter Thromb Vasc Biol. 1997;17:646-653.
20. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem. 1991;266:17261-17268.
21. Hoffman M, Monroe DM, Roberts HR. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost. 1992;68:74-78.
22. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991;77:2641-2648.
23. Nishioka J, Ning M, Hayashi T, Suzuki L. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J Biol Chem. 1998;273:11281-11287.
24. Dachery-Prigent J, Freyssinet J-M, Pasquet J-M, Carron J-C, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood. 1993;81:2554-2565.
25. Pasquet J-M, Dachery-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem. 1996;239:647-654.
26. Jy W, Horstman LL, Acre M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119:334-345.
27. Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost. 1994;72:666-671.
28. Singh N, Gemmell CH, Daly PA, Yeo EL. Elevated platelet-derived microparticle levels in unstable angina. Can J Cardiol. 1995;11:1015-1021.
29. Strano A, Davi G, Patrono C. In vivo platelet activation in diabetes mellitus. Sem Thromb Haemost. 1991;17:422-425.
30. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, Tablin F. Platelet activation in patients with sickle cell disease. Br J Haem. 1998;100:741-749.
31. Holme PA, Muller F, Solum NO, Brosstad F, Froland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 1998;12:79-90.
32. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PGM, ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997;96:3534-3541.
33. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Newman PJ. Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986;78:340-348.
34. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct activation of activated platelets and platelet-derived microparticles in humans. Blood. 1990;75:128-138.
35. Wencel-Drake JD, Dieter MG, Lam SC-T. Immunolocalization of β1 integrins in platelets and platelet-derived microvesicles. Blood. 1993;82:1197-1203.
36. Silijander P, Carpen O, Lassilia R. Platelet-derived microparticles associate with fibrin deposition during thrombosis. Blood. 1996;87:4651-4663.
37. Bizios R, Lai LC, Cooper JA, Del Vecchio PJ, Malik AB. Thrombin-induced adherence of neutrophils to cultured endothelial monolayers: increased endothelial adhesiveness. J Cell Physiol. 1988;134:275-280.
38. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995;80:919-927.
39. Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 1997;99:2118-2127.
40. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991;1083:1-17.
41. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Arachidonic acid in platelet microparticles upregulates cyclooxygenase-2 dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J Biol Chem. 1999;274:7545-7556.
42. Smith WL, DeWitt DL. Prostaglandin Endoperoxide H Synthases-1 and 2. In: Dixon FJ, ed. Advances in Immunology, vol. 62. Orlando, FL: Academic Press; 1996:167-215.
43. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993;268:9049-9054.
44. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 1987;75:636-642.
45. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med. 1991;91:35-95.
46. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, Kido H, Kagawa T, Fukahara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 1995;116:235-240.
47. Kelton JG, Warkentin TE, Hayward CPM, Murphy WG, Moore JC. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood. 1992;80:2246-2251.
48. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ. Res. 1993;72:239-245.
49. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest. 1998;102:136-144.
50. Satta N, Toti F, Feugeas O. Bohbot A, Dachary-Prigent J, Eschwege V, Hedmna H, Freyssinet JH. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153:3245-3255.
51. Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest. 1980;66:9797-9806.
52. Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Serhan CN, Weissman G. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions. Clin Physiol Biochem. 1984;2:78-83.
53. Marcus AJ. Eicosanoid interaction between platelets, endothelial cells, and neutrophils. Methods Enzymol. 1990;187;585-599.
54. Zembowicz A, Jones SL, Wu KK. Induction of cyclooxygenase-2 in human umbilical vein cells by lysophosphatidylcholine. J Clin Invest. 1995;96:1688-1692.
55. Reiser COA, Lanz T, Hofmann F, Hofer G, Rupprecht HD, Goppelt-Struebe M. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins. Biochem J. 1998;330:1107-1114.
56. 2α. J Biol Chem. 1995;270:9800-9808.
57. Maclouf J, Folco G, Patrono C. Eicosanoids and iso-eicosanoids: constitutive and transcellular biosynthesis in vascular disease. Haem Thromb. 1998;79:691-795.
58. 2α increases platelet adhesion and reduces anti-adhesive and antiaggregatory effects of NO. Arter Thromb Vasc Biol. 1998;18:1248-1256.
59. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 1997;100:2028-2034.
60. Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem Sci. 1994;19:73-77.
61. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607-614.
62. Cano E, Mahadevan LC. Parallel signaling processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117-122.
63. Gupta S, Barrett T, Whitmarsch AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996;15:2760-2770.
64. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fischer SM, Livi GP, White JR, Adams JL, Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739-746.
65. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156-160.